-
10 Cannabis Leaders Discuss Latest Innovations At Benzinga Cannabis Capital Conference
Wednesday, February 26, 2020 - 1:50pm | 1218This year’s six annual Benzinga Cannabis Capital Conference was the biggest and best yet, featuring dozens of executives, entrepreneurs and influencers within the global cannabis industry. These industry leaders participated in a range of panels, presentations and networking events and shared...
-
'Arguably The Fastest-Growing Business In The World': 6 Investment Pitches From The Cannabis Capital Conference
Sunday, October 27, 2019 - 3:45pm | 973Executives from several companies in or adjacent to the cannabis industry delivered their elevator pitches to investors this week at the Benzinga Cannabis Capital Conference in Chicago. Akerna: On Track to Hit Earnings Guidance Akerna Corp. (NASDAQ: KERN), a SaaS software provider to the...
-
GMP Upgrades Canopy Growth To Buy Following Acreage Deal
Monday, April 22, 2019 - 12:57pm | 356Cannabis stocks were mostly higher Monday after Canopy Growth Corp (NYSE: CGC) received positive coverage from an analyst. The Analysts GMP Securities' Martin Landry upgraded Canopy Growth from Hold to Buy with a price target lifted from $65 to $72. The Thesis Canopy Growth last week secured...
-
GMP Downgrades Canopy Growth After Mixed Q3
Tuesday, February 19, 2019 - 1:30pm | 458Canadian cannabis company Canopy Growth Corp (NYSE: CGC) reported third-quarter results last week that were highlighted by the first revenue beat in the past four quarters, but a gross margins of 22 percent was the worst seen in three years, according to GMP. The Analyst GMP Securities' Martin...
-
GMP Downgrades Cronos On Steep Valuation, Still Thinks It Has 'Bright Outlook'
Tuesday, February 5, 2019 - 10:40am | 399Cannabis stock Cronos Group, Inc. (NYSE: CRON) has been one of the hottest stocks in the market in 2019, gaining 115 percent year-to-date. However, one analyst said Tuesday Cronos stock has come too far too fast. The Analyst GMP analyst Martin Landry downgraded Cronos from Buy to Hold and...
-
GMP Lifts Canopy Growth Price Target After New York Grants Company Hemp License
Tuesday, January 15, 2019 - 12:28pm | 378Canadian cannabis company Canopy Growth Corp (NYSE: CGC) confirmed Monday that it received a license to produce and process hemp in New York, prompting GMP to turn incrementally bullish on the stock. The Analyst Analyst Martin Landry maintains a Buy rating on Toronto-listed Canopy Growth ...
-
Cronos Group, Analyst Respond To Citron's Short Report
Friday, August 31, 2018 - 2:55pm | 555Cronos Group Inc (NASDAQ: CRON) stock bounced back by 8.8 percent Friday after a 30-percent Thursday sell-off. The decline stemmed from accusations from Citron Research that Cronos is deceiving investors by not disclosing the size of its distribution agreements with Canadian provinces. Citron...